NCT00765388

Brief Summary

Background Urostomy is a surgical procedure that detours or diverts urine away form a diseased or defective bladder. The bladder can be removed and the urine is passed out of the body through an opening (stoma) in the stomach. People with urostomy will not be able to start and stop urine coming out through the stoma, so a urostomy bag will be fitted to collect the urine as it comes out. A urostomy bag consists of an adhesive, which is attached to the skin around the stoma and a bag connected to the adhesive to collect the urine. It is very important the standard is high on these products; otherwise the user (urostomy-patient) will experience lots of problems with the skin around the stoma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2008

Shorter than P25 for phase_4

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2008

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2008

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
4.9 years until next milestone

Results Posted

Study results publicly available

March 11, 2014

Completed
Last Updated

March 11, 2014

Status Verified

August 1, 2012

Enrollment Period

7 months

First QC Date

October 1, 2008

Results QC Date

September 19, 2011

Last Update Submit

January 27, 2014

Conditions

Keywords

urostomy, 1-piece, cross-over, randomised, preference

Outcome Measures

Primary Outcomes (1)

  • Preference of Sensura vs Moderma

    Subjects were asked which of the tested products they preferred; SenSura or Moderma.

    4 weeks

Secondary Outcomes (11)

  • Immediate Adhesion

    4 weeks

  • Removal of the Bag

    4 weeks

  • Adhesion of the Bag During Use

    4 weeks

  • Adhesives Ability to Absorb Perspiration

    4 weeks

  • Flexibility of the Product

    4 weeks

  • +6 more secondary outcomes

Study Arms (2)

SenSura Uro

EXPERIMENTAL

The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.

Device: SenSura Uro

hollister Uro

ACTIVE COMPARATOR

The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive

Device: Hollister

Interventions

The test product is a CE-marked non-sterile one-piece urostomy multi-chamber bag with the SenSura adhesive.

Also known as: SenSura URO Standard Wear 1-piece bag, Product number:1438298
SenSura Uro
HollisterDEVICE

The comparator product is CE-marked and non-sterile and produced for urostomy operated. It is a flat one-piece urostomy product, Hollister Moderma Flex Urostomy beige, Cut-to-Fit Bag, flat adhesive.

Also known as: Moderma Flex Urostomy, Cut-to-fit bag, flat adhesive., product id : 29100
hollister Uro

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In order to be enrolled in the clinical investigation, the subject must:
  • Be at least 18 years old,
  • Be mentally and physically capable of signing the written consent form
  • Be able to fill in the Case Report Form (questionnaire)
  • Have an urostomy with a size between 15-55 mm.
  • Have had the urostomy for 3 months or more,
  • Use a 1-piece bag normally.
  • Be able to handle the bag themselves (application and removal)
  • Be willing to use Coloplast SenSura 1-piece bag
  • Be willing to use Hollisters Moderma Flex, 1-piece bag

You may not qualify if:

  • In order to be enrolled in the clinical investigation, the subjects must not:
  • Be a convex base plate user (i.e. a bowl-shaped adhesive which pushes the stoma forward)
  • Need to use an ostomy belt
  • Be currently suffering from any dermatologiacal problems, needing special treatment, in the peristomal area (investigator will evaluate skin according to a newly developed ostomy skin tool from Coloplast A/S)
  • Being treated with chemo- or radiation therapy,
  • Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
  • Be pregnant or breast-feeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

St. Peters Hospital

Chertsey, Surrey, KT16OPZ, United Kingdom

Location

Caroline Rudoni

London, Tooting, SW17OQT, United Kingdom

Location

Maureen Bridgland

Brighton, United Kingdom

Location

Michael Lynch

Colchester, CO45JL, United Kingdom

Location

University of London Hospital

London, WC1E 5DB, United Kingdom

Location

Theresa Bowles

Norwich, United Kingdom

Location

Results Point of Contact

Title
Seema Suchdev Wrisberg
Organization
Coloplast A/S

Study Officials

  • Carol Katte, Stoma Nurse

    Ashford and St. Peters Hospital

    STUDY CHAIR
  • Maureen Bridgland, Stoma Nurse

    Royal Sussex County Hospital

    PRINCIPAL INVESTIGATOR
  • Caroline Rudoni, Stoma Nurse

    St. Georges Hospital

    PRINCIPAL INVESTIGATOR
  • Theresa Bowles, Stoma Nurse

    Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

    PRINCIPAL INVESTIGATOR
  • Michael Lynch, Surgeon

    Colchester General Hospital

    PRINCIPAL INVESTIGATOR
  • Sharon Fillingham, Nurse

    UCLH

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2008

First Posted

October 2, 2008

Study Start

October 1, 2008

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

March 11, 2014

Results First Posted

March 11, 2014

Record last verified: 2012-08

Locations